Cooley advised Kriya on the fundraising. Kriya Therapeutics, Inc. announced the addition of over $150 million in capital committed as part of its Series C Financing,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here